Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  PEP-CMV vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
PEP-CMV Vaccine and Temozolomide in Treating Patients with Glioblastoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: Pro00034208, NCI-2017-00566, NCT02864368
Start Over